3.3 - Vaginal DD

0.0(0)
studied byStudied by 0 people
0.0(0)
full-widthCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/24

encourage image

There's no tags or description

Looks like no tags are added yet.

Study Analytics
Name
Mastery
Learn
Test
Matching
Spaced

No study sessions yet.

25 Terms

1
New cards

vaginal route local effect

used for vaginal infections, lubrication, contraception

2
New cards

vaginal route systemic effect

- not common route

- research ongoing

- good for highly metabolized drugs (no hepatic first pass effect)

3
New cards

vaginal dosage forms

liquids, semisolids, solids

4
New cards

liquid dosage form

douche

5
New cards

semisolid dosage form

creams, gels, ointments, foams

6
New cards

solid dosage forms

suppositories/compressed tablets (Pessary, Ovule, Insert), and film 

7
New cards

film dosage form

- rapidly disintegrating polymer sheet

- drug uniformly dispersed and dissolved

8
New cards

gross anatomy of vagina

- fibromuscular tube (6-10 cm long in adult)

- extends from cervix

<p>- fibromuscular tube (6-10 cm long in adult)</p><p>- extends from cervix</p>
9
New cards

vaginal mucosa

- stratified squamous epithelium (skin-like)

- contains rugae (folds → increase SA/aid in retention)

- contains natural microflora (Lactobacilli)

10
New cards

vaginal epithelium

- SC has dead corneocytes

- intercellular lipids present

- does NOT form impermeable intercellular lipid envelope

- more permeable than skin SC

11
New cards

mucous layer of vagina

- limited amount, complex fluid

- source = cervical secretions

- contains transudates, exfoliated cells, leukocytes 

12
New cards

pH of vagina

- generally low/acidic (due to lactic acid from Lactobacilli; bacteriostatic)

13
New cards

other features of the vagina

- presence of enzymes

- relatively limited SA (vs GI tract)

- venous drainage NOT to hepatic portal system (NO first pass)

14
New cards

Variations in Mucosa

- fluid amount/consistency varies (Menstrual cycles)

- pH is higher: age 4 wks to puberty or upon menopause

- epithelium thickness changes (thinner upon menopause)

15
New cards

systemic drug absroption

- good for some drugs (large molecules/peptides)

- limited for most current products

- significant interpatient variability 

- affected by mucosal variations

16
New cards

dosage form considerations

product pH, microbial presence, attributes post-administration, administration aids

17
New cards

product pH

- consider natural vaginal pH (acidic)

- formulate low pH to match if possible

- important for drug solubility and stability

- avoid strong buffer capacity (allows fluids to control pH)

18
New cards

Microbial Prescence

- must be free of microorganisms, yeast, and molds

- do NOT disrupt natural microflora

19
New cards

Attributes post-administration

- retention → long enough for distribution

- liquefaction → solids must melt/dissolve rapidly

- distribution → should spread well

- spreading ranking: foams/liquids > suppositories > disintegrating tablets

- leakage → should NOT be excessive or too quick

20
New cards

administration aids

- applicators usually required

- supplied w/ drug product

- products often designed for high insertion

21
New cards

Imvexxy

- estradiol vaginal inserts

- used for moderate to severe dyspareunia

22
New cards

Clotrimazole Vaginal Cram and Vagistat Ointment

used in treatment of Candidasis

23
New cards

Cleocin Suppository and Metronidazole Vaginal Gel

used in treatment of bacterial vaginosis

24
New cards

Crinone gel

- used as a progesterone supplementation

- bioadhesive gel (polycarbophil)

25
New cards

VCF Film

- fast-dissolving polymer film (nonoxynol-9)

- used in contraception